verve records - Search News

News

Verve, Eli Lilly and Therapeutics

Barron's on MSN · 23h

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

UPI on MSN · 19h

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

The Wall Street Journal on MSN · 20h

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

2h

Lock In The 81.5% Run - Initiating Verve With A Sell

Verve Therapeutics remains an early-stage biotech, making the rally purely acquisition-driven, not based on fundamentals.

Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

22hon MSN

Why Verve Therapeutics Stock Is Skyrocketing Today

Eli Lilly plans to acquire Verve for up to $1.3 billion. Shares of Verve Therapeutics (NASDAQ: VERV) were skyrocketing 75.7% ...

uDiscoverMusic12d

The Verve’s ‘Urban Hymns’ Is Returning To Vinyl

The Verve’s founder and lead singer, Richard Ashcroft, became a solo act in 2000. He recently released the single “Lover,” ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results